首页 > 资讯
Ascom Annual General Meeting approves increased dividend payout of CHF 0.30
2024-04-17 08:59:39 资讯 Ascom Holding AGAd hoc announcement pursuant to Art. 53 LR
Baar, Switzerland, April 16, 2024
At the Annual General Meeting held in Zug on April 16, 2024, the shareholders of Ascom Holding AG approved all proposals of the Board of Directors by a large majority, except for the Remuneration Report.
The Annual General Meeting was attended by 79 shareholders. A total of 23’654’461 registered shares with voting rights were represented, which corresponds to 65,7 % of the share capital.
The Annual General Meeting approved most proposals of the Board of Directors with a large majority, including the report on non-financial matters and the payout of an increased dividend of CHF 0.30 per share.
However, the shareholders rejected the remuneration report with a slight majority in a consultative vote. The Board of Directors values this feedback and will consider it in its future assessment of the compensation policy.
Dr. Monika Krüsi was elected as a new member of the Board of Directors, replacing Dr. Andreas Schönenberger, who did not stand for re-election. Moreover, the shareholders re-elected the current members Dr. Valentin Chapero Rueda, Nicole Burth Tschudi, Laurent Dubois, Jürg Fedier and Michael Reitermann for another term of office of one year. Dr. Valentin Chapero Rueda was confirmed also as Chairman of the Board of Directors.
Attachment
相关推荐
- 欧洲智慧能源展:双向充电可节省数十亿美元
- Diligent宣布推出由S&P Global市场情报部门提供支持的Market Insights Reporting,为董事和高管提供无与伦比的财务和风险洞察
- 戴尔科技 x 赛轮集团:打造橡胶行业首个工业互联网平台
- 世贸通美国EB5投资移民: I-956F拒签率近16%,这个局怎么破?
- 世贸通美国EB5投资移民: I-956F拒签率近16%,这个局怎么破?
- 全球首款!智翔金泰狂犬病被动免疫双抗斯乐韦米单抗申报上市
- 逸夫眼镜匠心之选备受认可 获得行业多项殊荣
- 健康新生态·聚势赢未来丨伽澜健康集团年度伽友峰会在京圆满举办
- 嘻哈包袱铺开启全球巡演,首战新加坡,圆满成功!
- 九三学社秦皇岛社员付占一博士后研究员入选英国皇家工艺院终身院士
- 搜索
-
- 01-16欧洲智慧能源展:双向充电可节省数十亿美元
- 01-16Diligent宣布推出由S&P Global市场情报部门提供支持的Market Insights Reporting,为董事和高管提供无与伦比的财务和风险洞察
- 01-16戴尔科技 x 赛轮集团:打造橡胶行业首个工业互联网平台
- 01-16世贸通美国EB5投资移民: I-956F拒签率近16%,这个局怎么破?
- 01-16世贸通美国EB5投资移民: I-956F拒签率近16%,这个局怎么破?
- 01-16全球首款!智翔金泰狂犬病被动免疫双抗斯乐韦米单抗申报上市
- 01-16逸夫眼镜匠心之选备受认可 获得行业多项殊荣
- 01-16健康新生态·聚势赢未来丨伽澜健康集团年度伽友峰会在京圆满举办
- 01-16嘻哈包袱铺开启全球巡演,首战新加坡,圆满成功!
- 01-16九三学社秦皇岛社员付占一博士后研究员入选英国皇家工艺院终身院士
- 标签列表